IQVIA’s OHDSI/OMOP Services enable faster, reproducible real-world evidence (RWE) generation by transforming disparate health data into the OMOP Common Data Model (CDM). With access to 300+ datasets from 31+ countries, representing 2.5B+ patient records, this solution offers efficiency, reliability, and reduced costs. Services include ETL conversions, OMOP Converter software, training, publication support, and consulting. Productized analytics accelerate feasibility studies, cohort analyses, and outcomes research. IQVIA, a major OMOP contributor and FDA partner, provides global expertise, validated tools, and scalable capabilities, making multi-database research faster, consistent, and cost-effective.

Join for free to read